Japanese Healthtech Stock News

TSE:7013
TSE:7013Machinery

IHI (TSE:7013) Could Be 23% Undervalued As Earnings And Guidance Improve

IHI (TSE:7013) came into focus after reporting first quarter sales of ¥374,548 million and net income of ¥53,518 million, alongside revised consolidated earnings guidance for the fiscal year ending March 31, 2027. See our latest analysis for IHI. IHI’s latest quarterly update and revised guidance appear to sit behind a sharp swing in sentiment, with a 1 day share price return of 4.98% and a 7 day share price return of 7.62% contrasting with a year to date share price decline of 3.51%, while...
TSE:4183
TSE:4183Chemicals

Mitsui Chemicals (TSE:4183) Could Be 34% Undervalued As New Guidance Tests Valuation

Why Mitsui Chemicals Stock Is In Focus After New Guidance Mitsui Chemicals (TSE:4183) drew fresh attention after issuing first half 2026 earnings guidance alongside updated dividend plans and a Q1 2027 earnings call, giving investors new numbers to assess cash flows and payout expectations. See our latest analysis for Mitsui Chemicals. Over the past year Mitsui Chemicals has seen a 1 year total shareholder return of 28.94%, while the year to date share price return of 10.45% and 30 day share...
TSE:3407
TSE:3407Chemicals

Asahi Kasei (TSE:3407) Is Up 6.1% After Licensing Electrolyte Technology To HighChem In China – What's Changed

In August 2026, Asahi Kasei Corporation announced a non-exclusive license agreement allowing HighChem Shanghai to produce and sell its Acetolyte acetonitrile-containing electrolyte technology in China’s high-performance lithium-ion battery market. This first Chinese license builds on earlier European deals and supports Asahi Kasei’s Technology-value Business Creation plan to monetize its technology through at least 10 new licenses by fiscal 2027. We’ll now examine how this China-focused...
TSE:4028
TSE:4028Chemicals

Discovering Asia's Undiscovered Gems In August 2026

In August 2026, the Asian markets are experiencing a dynamic phase, with key indices like the S&P 600 for small-cap stocks showing resilience amid global economic fluctuations and geopolitical developments. As investors navigate this landscape marked by optimism around technological advancements and easing energy concerns, identifying promising small-cap companies becomes crucial for those looking to capitalize on growth opportunities in Asia's diverse economies.
TSE:3436
TSE:3436Semiconductor

Why Did Sumco (TSE:3436) Move After Its Latest Update?

Why Sumco stock is in focus after the latest earnings update Sumco (TSE:3436) is back on investors' radar after half year 2026 results showed a shift from last year's profit to a net loss, alongside maintained dividends and guidance that still points to further losses. The company reported sales of ¥215,016 million for the half year to June 30, 2026, compared with ¥205,372 million a year earlier, while net income moved to a loss of ¥12,895 million from a profit of ¥3,081 million. See our...
TSE:1980
TSE:1980Construction

Why Dai-Dan (TSE:1980) Is Down 7.7% After Cutting Dividends With New 2027 Guidance

Earlier this month, Dai-Dan Co., Ltd. reported first quarter 2026 results, issued consolidated guidance for the fiscal year ending March 31, 2027, and updated its dividend outlook following a 3-for-1 stock split effective January 1, 2026. The company’s guidance combines expectations for ¥265,000 million in net sales and profit per share of ¥211.42 with a lower full-year dividend of ¥43.00 per share compared with the prior year. We’ll now examine how Dai-Dan’s combination of new full-year...
TSE:4061
TSE:4061Chemicals

Denka (TSE:4061) Raised Profit Guidance, Is The Valuation Still Justified?

Denka guidance update and what it means for investors Denka (TSE:4061) raised its operating profit outlook for the first half of the fiscal year ending March 2027, after reporting first quarter results, while guiding to lower net sales and flagging an expected extraordinary loss. The revised forecast now points to first half net sales of ¥205,000 million and operating income of ¥17,000 million, compared with the previous projection of ¥210,000 million in net sales and ¥12,000 million in...